<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 11 Aug 2026 06:01:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  N-PX       JOHNSON &amp;amp; JOHNSON     For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++N-PX+++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Jun+30/26900361.html</link>
   <description>si-local-file:///var/storage/secattach/20260811/26900361.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++N-PX+++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Jun+30/26900361.html</guid>
   <pubDate>Tue, 11 Aug 2026 06:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Form  N-PX       JOHNSON &amp;amp; JOHNSON     For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++N-PX+++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Jun+30/26900361.html</link>
   <description>si-local-file:///var/storage/secattach/20260811/26900361.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++N-PX+++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Jun+30/26900361.html</guid>
   <pubDate>Tue, 11 Aug 2026 06:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Johnson &amp;amp; Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Johnson+%26amp%3B+Johnson+to+Participate+in+the+Morgan+Stanley+24th+Annual+Global+Healthcare+Conference/26898375.html</link>
   <description>
&lt;p&gt;    NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--
Johnson &amp;amp; Johnson (NYSE: JNJ) will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14th, 2026. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time.

&lt;/p&gt;&lt;p&gt;
A live audio webcast of the presentation will be accessible through Johnson &amp;amp; Johnson's Investor Relations website at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.investor.jnj.com%2F&amp;amp;esheet=54587267&amp;amp;newsitemid=20260810189263&amp;amp;lan=en-US&amp;amp;anchor=www.investor.jnj.com&amp;amp;index=1&amp;amp;md5=a6d53ef922ed14ea6e0cf36a73c081b1&quot; shape=&quot;rect&quot;&gt;www.investor.jnj.com&lt;/a&gt;. An archived edition of the session will be available later that day.

&lt;/p&gt;&lt;p&gt;
The audio webcast replay will be available approximately 48 hours after the webcast.

&lt;/p&gt;&lt;p&gt;&lt;img alt=&quot;&quot; src=&quot;https://cts.businesswire.com/ct/CT?id=bwnews&amp;amp;sty=20260810189263r1&amp;amp;sid=acqr8&amp;amp;distro=nx&amp;amp;lang=en&quot; style=&quot;width:0;height:0&quot; /&gt;&lt;span class=&quot;bwct31415&quot; /&gt;&lt;/p&gt;&lt;p id=&quot;mmgallerylink&quot;&gt;&lt;span id=&quot;mmgallerylink-phrase&quot;&gt;View source version on &lt;a target=&quot;_blank&quot; href=&quot;http://businesswire.com&quot;&gt;businesswire.com&lt;/a&gt;:</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Johnson+%26amp%3B+Johnson+to+Participate+in+the+Morgan+Stanley+24th+Annual+Global+Healthcare+Conference/26898375.html</guid>
   <pubDate>Mon, 10 Aug 2026 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Johnson &amp;amp; Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Johnson+%26amp%3B+Johnson+to+Participate+in+the+Morgan+Stanley+24th+Annual+Global+Healthcare+Conference/26898375.html</link>
   <description>
&lt;p&gt;    NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--
Johnson &amp;amp; Johnson (NYSE: JNJ) will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14th, 2026. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time.

&lt;/p&gt;&lt;p&gt;
A live audio webcast of the presentation will be accessible through Johnson &amp;amp; Johnson's Investor Relations website at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.investor.jnj.com%2F&amp;amp;esheet=54587267&amp;amp;newsitemid=20260810189263&amp;amp;lan=en-US&amp;amp;anchor=www.investor.jnj.com&amp;amp;index=1&amp;amp;md5=a6d53ef922ed14ea6e0cf36a73c081b1&quot; shape=&quot;rect&quot;&gt;www.investor.jnj.com&lt;/a&gt;. An archived edition of the session will be available later that day.

&lt;/p&gt;&lt;p&gt;
The audio webcast replay will be available approximately 48 hours after the webcast.

&lt;/p&gt;&lt;p&gt;&lt;img alt=&quot;&quot; src=&quot;https://cts.businesswire.com/ct/CT?id=bwnews&amp;amp;sty=20260810189263r1&amp;amp;sid=acqr8&amp;amp;distro=nx&amp;amp;lang=en&quot; style=&quot;width:0;height:0&quot; /&gt;&lt;span class=&quot;bwct31415&quot; /&gt;&lt;/p&gt;&lt;p id=&quot;mmgallerylink&quot;&gt;&lt;span id=&quot;mmgallerylink-phrase&quot;&gt;View source version on &lt;a target=&quot;_blank&quot; href=&quot;http://businesswire.com&quot;&gt;businesswire.com&lt;/a&gt;:</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Johnson+%26amp%3B+Johnson+to+Participate+in+the+Morgan+Stanley+24th+Annual+Global+Healthcare+Conference/26898375.html</guid>
   <pubDate>Mon, 10 Aug 2026 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Johnson &amp;amp; Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Business+Wire/Johnson+%26amp%3B+Johnson+to+Participate+in+the+Morgan+Stanley+24th+Annual+Global+Healthcare+Conference/26898375.html</link>
   <description>
&lt;p&gt;    NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--
Johnson &amp;amp; Johnson (NYSE: JNJ) will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14th, 2026. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time.

&lt;/p&gt;&lt;p&gt;
A live audio webcast of the presentation will be accessible through Johnson &amp;amp; Johnson's Investor Relations website at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.investor.jnj.com%2F&amp;amp;esheet=54587267&amp;amp;newsitemid=20260810189263&amp;amp;lan=en-US&amp;amp;anchor=www.investor.jnj.com&amp;amp;index=1&amp;amp;md5=a6d53ef922ed14ea6e0cf36a73c081b1&quot; shape=&quot;rect&quot;&gt;www.investor.jnj.com&lt;/a&gt;. An archived edition of the session will be available later that day.

&lt;/p&gt;&lt;p&gt;
The audio webcast replay will be available approximately 48 hours after the webcast.

&lt;/p&gt;&lt;p&gt;&lt;img alt=&quot;&quot; src=&quot;https://cts.businesswire.com/ct/CT?id=bwnews&amp;amp;sty=20260810189263r1&amp;amp;sid=acqr8&amp;amp;distro=nx&amp;amp;lang=en&quot; style=&quot;width:0;height:0&quot; /&gt;&lt;span class=&quot;bwct31415&quot; /&gt;&lt;/p&gt;&lt;p id=&quot;mmgallerylink&quot;&gt;&lt;span id=&quot;mmgallerylink-phrase&quot;&gt;View source version on &lt;a target=&quot;_blank&quot; href=&quot;http://businesswire.com&quot;&gt;businesswire.com&lt;/a&gt;:</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Johnson+%26amp%3B+Johnson+to+Participate+in+the+Morgan+Stanley+24th+Annual+Global+Healthcare+Conference/26898375.html</guid>
   <pubDate>Mon, 10 Aug 2026 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Johnson &amp;amp; Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Business+Wire/Johnson+%26amp%3B+Johnson+to+Participate+in+the+Morgan+Stanley+24th+Annual+Global+Healthcare+Conference/26898375.html</link>
   <description>
&lt;p&gt;    NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--
Johnson &amp;amp; Johnson (NYSE: JNJ) will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14th, 2026. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time.

&lt;/p&gt;&lt;p&gt;
A live audio webcast of the presentation will be accessible through Johnson &amp;amp; Johnson's Investor Relations website at &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.investor.jnj.com%2F&amp;amp;esheet=54587267&amp;amp;newsitemid=20260810189263&amp;amp;lan=en-US&amp;amp;anchor=www.investor.jnj.com&amp;amp;index=1&amp;amp;md5=a6d53ef922ed14ea6e0cf36a73c081b1&quot; shape=&quot;rect&quot;&gt;www.investor.jnj.com&lt;/a&gt;. An archived edition of the session will be available later that day.

&lt;/p&gt;&lt;p&gt;
The audio webcast replay will be available approximately 48 hours after the webcast.

&lt;/p&gt;&lt;p&gt;&lt;img alt=&quot;&quot; src=&quot;https://cts.businesswire.com/ct/CT?id=bwnews&amp;amp;sty=20260810189263r1&amp;amp;sid=acqr8&amp;amp;distro=nx&amp;amp;lang=en&quot; style=&quot;width:0;height:0&quot; /&gt;&lt;span class=&quot;bwct31415&quot; /&gt;&lt;/p&gt;&lt;p id=&quot;mmgallerylink&quot;&gt;&lt;span id=&quot;mmgallerylink-phrase&quot;&gt;View source version on &lt;a target=&quot;_blank&quot; href=&quot;http://businesswire.com&quot;&gt;businesswire.com&lt;/a&gt;:</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Johnson+%26amp%3B+Johnson+to+Participate+in+the+Morgan+Stanley+24th+Annual+Global+Healthcare+Conference/26898375.html</guid>
   <pubDate>Mon, 10 Aug 2026 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Form  4          JOHNSON &amp;amp; JOHNSON     For: Aug 05  Filed by: Duato Joaquin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Aug+05++Filed+by%3A+Duato+Joaquin/26892381.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26892381.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Aug+05++Filed+by%3A+Duato+Joaquin/26892381.html</guid>
   <pubDate>Fri, 07 Aug 2026 17:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Form  4          JOHNSON &amp;amp; JOHNSON     For: Aug 05  Filed by: Duato Joaquin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Aug+05++Filed+by%3A+Duato+Joaquin/26892381.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26892381.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Aug+05++Filed+by%3A+Duato+Joaquin/26892381.html</guid>
   <pubDate>Fri, 07 Aug 2026 17:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Form  4          JOHNSON &amp;amp; JOHNSON     For: Aug 06  Filed by: Forminard Elizabeth</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Aug+06++Filed+by%3A+Forminard+Elizabeth/26892364.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26892364.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Aug+06++Filed+by%3A+Forminard+Elizabeth/26892364.html</guid>
   <pubDate>Fri, 07 Aug 2026 17:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Form  4          JOHNSON &amp;amp; JOHNSON     For: Aug 06  Filed by: Forminard Elizabeth</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Aug+06++Filed+by%3A+Forminard+Elizabeth/26892364.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26892364.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Aug+06++Filed+by%3A+Forminard+Elizabeth/26892364.html</guid>
   <pubDate>Fri, 07 Aug 2026 17:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Morgan Stanley tracks US drug market prescriptions for week ending July 31</title>
   <link>http://www.streetinsider.com/General+News/Morgan+Stanley+tracks+US+drug+market+prescriptions+for+week+ending+July+31/26889641.html</link>
   <description>&lt;p&gt;Investing.com -- Morgan Stanley released its weekly analysis of US prescription drug market data for the week ending July 31, showing total prescription year-over-year growth of 1.5% compared to 2.0% the previous week and 1.3% over the past 12 weeks.&lt;/p&gt;&lt;p&gt;The rolling 4-week total prescription year-over-year change was -0.2%, while the rolling 12-week total prescription year-over-year change was 1.3%. Extended unit weekly year-over-year growth was 1.1%, below total prescription year-over-year growth. Sequential weekly total prescription growth was -0.5% compared to -0.4% the week before.&lt;/p&gt;&lt;p&gt;Bristol-Myers Squibb's (NYSE:BMY) Cobenfy, approved for schizophrenia on September 26, 2024, recorded approximately 3,370 scripts for the week</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Morgan+Stanley+tracks+US+drug+market+prescriptions+for+week+ending+July+31/26889641.html</guid>
   <pubDate>Fri, 07 Aug 2026 12:04:12 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
   	  </item>
  <item>
   <title>Morgan Stanley tracks US drug market prescriptions for week ending July 31</title>
   <link>http://www.streetinsider.com/General+News/Morgan+Stanley+tracks+US+drug+market+prescriptions+for+week+ending+July+31/26889641.html</link>
   <description>&lt;p&gt;Investing.com -- Morgan Stanley released its weekly analysis of US prescription drug market data for the week ending July 31, showing total prescription year-over-year growth of 1.5% compared to 2.0% the previous week and 1.3% over the past 12 weeks.&lt;/p&gt;&lt;p&gt;The rolling 4-week total prescription year-over-year change was -0.2%, while the rolling 12-week total prescription year-over-year change was 1.3%. Extended unit weekly year-over-year growth was 1.1%, below total prescription year-over-year growth. Sequential weekly total prescription growth was -0.5% compared to -0.4% the week before.&lt;/p&gt;&lt;p&gt;Bristol-Myers Squibb's (NYSE:BMY) Cobenfy, approved for schizophrenia on September 26, 2024, recorded approximately 3,370 scripts for the week</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Morgan+Stanley+tracks+US+drug+market+prescriptions+for+week+ending+July+31/26889641.html</guid>
   <pubDate>Fri, 07 Aug 2026 12:04:12 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
   	  </item>
  <item>
   <title>Morgan Stanley tracks US drug market prescriptions for week ending July 31</title>
   <link>http://www.streetinsider.com/General+News/Morgan+Stanley+tracks+US+drug+market+prescriptions+for+week+ending+July+31/26889641.html</link>
   <description>&lt;p&gt;Investing.com -- Morgan Stanley released its weekly analysis of US prescription drug market data for the week ending July 31, showing total prescription year-over-year growth of 1.5% compared to 2.0% the previous week and 1.3% over the past 12 weeks.&lt;/p&gt;&lt;p&gt;The rolling 4-week total prescription year-over-year change was -0.2%, while the rolling 12-week total prescription year-over-year change was 1.3%. Extended unit weekly year-over-year growth was 1.1%, below total prescription year-over-year growth. Sequential weekly total prescription growth was -0.5% compared to -0.4% the week before.&lt;/p&gt;&lt;p&gt;Bristol-Myers Squibb's (NYSE:BMY) Cobenfy, approved for schizophrenia on September 26, 2024, recorded approximately 3,370 scripts for the week</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Morgan+Stanley+tracks+US+drug+market+prescriptions+for+week+ending+July+31/26889641.html</guid>
   <pubDate>Fri, 07 Aug 2026 12:04:12 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
   	  </item>
  <item>
   <title>Morgan Stanley tracks US drug market prescriptions for week ending July 31</title>
   <link>http://www.streetinsider.com/General+News/Morgan+Stanley+tracks+US+drug+market+prescriptions+for+week+ending+July+31/26889641.html</link>
   <description>&lt;p&gt;Investing.com -- Morgan Stanley released its weekly analysis of US prescription drug market data for the week ending July 31, showing total prescription year-over-year growth of 1.5% compared to 2.0% the previous week and 1.3% over the past 12 weeks.&lt;/p&gt;&lt;p&gt;The rolling 4-week total prescription year-over-year change was -0.2%, while the rolling 12-week total prescription year-over-year change was 1.3%. Extended unit weekly year-over-year growth was 1.1%, below total prescription year-over-year growth. Sequential weekly total prescription growth was -0.5% compared to -0.4% the week before.&lt;/p&gt;&lt;p&gt;Bristol-Myers Squibb's (NYSE:BMY) Cobenfy, approved for schizophrenia on September 26, 2024, recorded approximately 3,370 scripts for the week</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Morgan+Stanley+tracks+US+drug+market+prescriptions+for+week+ending+July+31/26889641.html</guid>
   <pubDate>Fri, 07 Aug 2026 12:04:12 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
   	  </item>
  <item>
   <title>Morgan Stanley tracks US drug market prescriptions for week ending July 31</title>
   <link>http://www.streetinsider.com/General+News/Morgan+Stanley+tracks+US+drug+market+prescriptions+for+week+ending+July+31/26889641.html</link>
   <description>&lt;p&gt;Investing.com -- Morgan Stanley released its weekly analysis of US prescription drug market data for the week ending July 31, showing total prescription year-over-year growth of 1.5% compared to 2.0% the previous week and 1.3% over the past 12 weeks.&lt;/p&gt;&lt;p&gt;The rolling 4-week total prescription year-over-year change was -0.2%, while the rolling 12-week total prescription year-over-year change was 1.3%. Extended unit weekly year-over-year growth was 1.1%, below total prescription year-over-year growth. Sequential weekly total prescription growth was -0.5% compared to -0.4% the week before.&lt;/p&gt;&lt;p&gt;Bristol-Myers Squibb's (NYSE:BMY) Cobenfy, approved for schizophrenia on September 26, 2024, recorded approximately 3,370 scripts for the week</description>
   <guid isPermaLink="true">http://www.streetinsider.com/General+News/Morgan+Stanley+tracks+US+drug+market+prescriptions+for+week+ending+July+31/26889641.html</guid>
   <pubDate>Fri, 07 Aug 2026 12:04:12 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
   	  </item>
  <item>
   <title>Form  144        JOHNSON &amp;amp; JOHNSON                  Filed by: Forminard Elizabeth</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++JOHNSON+%26amp%3B+JOHNSON++++++++++++++++++Filed+by%3A+Forminard+Elizabeth/26882554.html</link>
   <description>si-local-file:///var/storage/secattach/20260806/26882554.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++JOHNSON+%26amp%3B+JOHNSON++++++++++++++++++Filed+by%3A+Forminard+Elizabeth/26882554.html</guid>
   <pubDate>Thu, 06 Aug 2026 14:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Form  144        JOHNSON &amp;amp; JOHNSON                  Filed by: Forminard Elizabeth</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++JOHNSON+%26amp%3B+JOHNSON++++++++++++++++++Filed+by%3A+Forminard+Elizabeth/26882554.html</link>
   <description>si-local-file:///var/storage/secattach/20260806/26882554.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++JOHNSON+%26amp%3B+JOHNSON++++++++++++++++++Filed+by%3A+Forminard+Elizabeth/26882554.html</guid>
   <pubDate>Thu, 06 Aug 2026 14:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Form  13F-HR     JOHNSON &amp;amp; JOHNSON     For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++13F-HR+++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Jun+30/26881459.html</link>
   <description>si-local-file:///var/storage/secattach/20260806/26881459.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++13F-HR+++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Jun+30/26881459.html</guid>
   <pubDate>Thu, 06 Aug 2026 10:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Form  13F-HR     JOHNSON &amp;amp; JOHNSON     For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++13F-HR+++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Jun+30/26881459.html</link>
   <description>si-local-file:///var/storage/secattach/20260806/26881459.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++13F-HR+++++JOHNSON+%26amp%3B+JOHNSON+++++For%3A+Jun+30/26881459.html</guid>
   <pubDate>Thu, 06 Aug 2026 10:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Johnson &amp; Johnson (JNJ) PT Raised to $287 at Guggenheim</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Johnson+%26+Johnson+%28JNJ%29+PT+Raised+to+%24287+at+Guggenheim/26878008.html</link>
   <description>(Updated - August 6, 2026 7:39 AM EDT)

&lt;p&gt;Guggenheim analyst Vamil Divan raised the price target on Johnson &amp; Johnson (NYSE: JNJ) to $287.00 (from $270.00) while maintaining a Buy rating.&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;We hosted a site visit today to meet with senior members of JNJ's management team, including Joe Wolk (EVP and CFO), Tom Cavanaugh (Group Chairman Innovative Medicine, North America and recently promoted to EVP, Worldwide Chairman Innovative Medicine effective Sept 1), and Chris Cutie (VP, R&amp;D Bladder Cancer), as well as members of the JNJ Investor Relations team. Overall, the discussion reinforced our enthusiasm for the new product</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Johnson+%26+Johnson+%28JNJ%29+PT+Raised+to+%24287+at+Guggenheim/26878008.html</guid>
   <pubDate>Thu, 06 Aug 2026 07:39:39 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	  </item>
  <item>
   <title>Johnson &amp; Johnson (JNJ) PT Raised to $287 at Guggenheim</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Johnson+%26+Johnson+%28JNJ%29+PT+Raised+to+%24287+at+Guggenheim/26878008.html</link>
   <description>(Updated - August 6, 2026 7:39 AM EDT)

&lt;p&gt;Guggenheim analyst Vamil Divan raised the price target on Johnson &amp; Johnson (NYSE: JNJ) to $287.00 (from $270.00) while maintaining a Buy rating.&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;We hosted a site visit today to meet with senior members of JNJ's management team, including Joe Wolk (EVP and CFO), Tom Cavanaugh (Group Chairman Innovative Medicine, North America and recently promoted to EVP, Worldwide Chairman Innovative Medicine effective Sept 1), and Chris Cutie (VP, R&amp;D Bladder Cancer), as well as members of the JNJ Investor Relations team. Overall, the discussion reinforced our enthusiasm for the new product</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Johnson+%26+Johnson+%28JNJ%29+PT+Raised+to+%24287+at+Guggenheim/26878008.html</guid>
   <pubDate>Thu, 06 Aug 2026 07:39:39 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	  </item>
  <item>
   <title>Form  144        JOHNSON &amp;amp; JOHNSON                  Filed by: Duato Joaquin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++JOHNSON+%26amp%3B+JOHNSON++++++++++++++++++Filed+by%3A+Duato+Joaquin/26876308.html</link>
   <description>si-local-file:///var/storage/secattach/20260805/26876308.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++JOHNSON+%26amp%3B+JOHNSON++++++++++++++++++Filed+by%3A+Duato+Joaquin/26876308.html</guid>
   <pubDate>Wed, 05 Aug 2026 18:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Form  144        JOHNSON &amp;amp; JOHNSON                  Filed by: Duato Joaquin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++JOHNSON+%26amp%3B+JOHNSON++++++++++++++++++Filed+by%3A+Duato+Joaquin/26876308.html</link>
   <description>si-local-file:///var/storage/secattach/20260805/26876308.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++JOHNSON+%26amp%3B+JOHNSON++++++++++++++++++Filed+by%3A+Duato+Joaquin/26876308.html</guid>
   <pubDate>Wed, 05 Aug 2026 18:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	  </item>
  <item>
   <title>Helus Pharma names ex-Intra-Cellular president as CEO</title>
   <link>http://www.streetinsider.com/FDA/Helus+Pharma+names+ex-Intra-Cellular+president+as+CEO/26871906.html</link>
   <description>

&lt;p&gt;Helus Pharma (Nasdaq: HELP, Cboe CA: HELP), a clinical-stage company developing treatments for depression and anxiety, has appointed Michael Halstead as Chief Executive Officer, effective immediately, according to a statement from the company.&lt;/p&gt;

&lt;p&gt;Halstead previously served as President of Intra-Cellular Therapies, where he was involved in the launch and commercialization of CAPLYTA (lumateperone) and the company's $14.6 billion sale to Johnson &amp;amp; Johnson (NYSE: JNJ) in 2025. Before that role, he held senior positions at Warner Chilcott, where he oversaw a $3 billion acquisition of Procter &amp;amp; Gamble's pharmaceutical business in 2009 and the company's $8.5 billion sale to Actavis in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Helus+Pharma+names+ex-Intra-Cellular+president+as+CEO/26871906.html</guid>
   <pubDate>Wed, 05 Aug 2026 10:26:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17471648</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24598926</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216152</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ATAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DFTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HELP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.12458983</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.17008112</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19241221</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37286706</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38546254</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48309657</category>
   	  </item>
  <item>
   <title>Helus Pharma names ex-Intra-Cellular president as CEO</title>
   <link>http://www.streetinsider.com/FDA/Helus+Pharma+names+ex-Intra-Cellular+president+as+CEO/26871906.html</link>
   <description>

&lt;p&gt;Helus Pharma (Nasdaq: HELP, Cboe CA: HELP), a clinical-stage company developing treatments for depression and anxiety, has appointed Michael Halstead as Chief Executive Officer, effective immediately, according to a statement from the company.&lt;/p&gt;

&lt;p&gt;Halstead previously served as President of Intra-Cellular Therapies, where he was involved in the launch and commercialization of CAPLYTA (lumateperone) and the company's $14.6 billion sale to Johnson &amp;amp; Johnson (NYSE: JNJ) in 2025. Before that role, he held senior positions at Warner Chilcott, where he oversaw a $3 billion acquisition of Procter &amp;amp; Gamble's pharmaceutical business in 2009 and the company's $8.5 billion sale to Actavis in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Helus+Pharma+names+ex-Intra-Cellular+president+as+CEO/26871906.html</guid>
   <pubDate>Wed, 05 Aug 2026 10:26:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17471648</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24598926</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216152</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ATAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DFTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HELP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00000295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.12458983</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.17008112</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19241221</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37286706</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38546254</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48309657</category>
   	  </item>
 </channel>
</rss>
